Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.58 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallybio Corporation Common Stock (RLYB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RLYB moved +2.18% today.
| Metric | Value |
|---|---|
| Price | $14.58 |
| Market Cap | $74.70M |
| P/E Ratio | -5.06 |
| EPS | $-2.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.31 |
| 52-Week Low | $1.76 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $858.00K |
| Net Income | $-7.82M |
| Gross Margin | 0.00% |
RLYB analyst coverage data. Average price target: $0.00.